BioAge Labs (BIOA) Gross Profit (2024 - 2026)

BioAge Labs (BIOA) has 3 years of Gross Profit data on file, last reported at -$10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 226.27% year-over-year to -$10.4 million; the trailing twelve-month figure through Mar 2026 stood at -$47.6 million (down 33.46% YoY), and the FY2025 full-year result was -$40.5 million, down 8.95% from the prior year.
• Gross Profit climbed to -$10.4 million in Q1 2026, from -$15.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of -$3.2 million in Q1 2025 to a low of -$15.5 million in Q4 2025.
• A 3-year average of -$9.8 million and a median of -$10.4 million in 2026 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 31.08% in 2025 and sank 226.27% in 2026, its largest moves.
• Tracing BIOA's Gross Profit over 3 years: stood at -$13.4 million in 2024, then retreated by 16.31% to -$15.5 million in 2025, then jumped by 33.27% to -$10.4 million in 2026.
• Business Quant data shows BIOA's Gross Profit at -$10.4 million in Q1 2026, -$15.5 million in Q4 2025, and -$10.2 million in Q3 2025.